A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Tempus AI
Actym Therapeutics, Inc.
Day One Biopharmaceuticals, Inc.
Ikena Oncology
Elevation Oncology
Novartis
NantCell, Inc.
Ikena Oncology
Fate Therapeutics
Montefiore Medical Center
MacroGenics
Tocagen Inc.
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
sigma-tau i.f.r. S.p.A.
Masonic Cancer Center, University of Minnesota
Calando Pharmaceuticals